Stay updated on Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial
Sign up to get notified when there's something new on the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page.

Latest updates to the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page
- Check6 days agoChange DetectedRevision tag updated from v3.6.0 to v3.6.3, signaling a newer page version. This update does not modify study data, eligibility criteria, or other user-visible content.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedThe study record now shows termination and no longer recruiting participants. The page also adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study), normalizes the Intervention/Treatment header, and updates the page revision tag to v3.6.0.SummaryDifference0.4%

- Check28 days agoChange DetectedRevision label updated from v3.5.4 to v3.5.5, indicating a newer version of the page content. This change represents a page update and may include minor edits or clarifications.SummaryDifference0.0%

- Check49 days agoChange DetectedThe page now shows revision v3.5.4, replacing v3.5.3. This reflects a backend or formatting update rather than changes to study content.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check78 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Efficacy 50 mg NYX-783 QD vs. Placebo Clinical Trial page.